Backs the full sell into the 380–387 shelf: at entry $384 the risk to a stop above the 200-SMA is ~16 points against a ~36-point reward to the 347–348 shelf, a better-than-2:1 setup on a textbook rejection candle (45.9M shares, heaviest of the week).
Argues the balance sheet is real but already priced in — "great company, wrong price" — and that waiting for perfect clarity just means missing the liquidity the market is offering now.
Agrees the 380–387 zone is the right place to sell but calls the aggressive downside framing (+6% vs −20%) cherry-picked — the real near-term risk/reward to the 347–348 shelf is closer to symmetric, so this is a trim, not a high-conviction short.
Proposes limit orders into 380–387 at the low end of sizing, paired with a put spread (~$350–355 long / $335–340 short) through the Q3 delivery report rather than a resting stop, given TSLA's proven gap risk.
Rejects an unconditional sell at $372 as a timing bet dressed as risk management — that's mid-band chop, not "selling strength," and a resting stop at $400 can fill far higher given TSLA's history of gapping through technical levels (the Jul 23 −14.5% gap).
Would trim only a small portion (0.2–0.3x) if price actually rallies into 380–387, use a protective put or collar instead of a stop, and otherwise hold through the Q3 catalyst given the fortress balance sheet and recovering revenue trend.
Thesis: The bear side carries the positioning call, but only to underweight, not exit. At roughly $1.08 TTM EPS, TSLA trades near ~340x trailing earnings while Q2 gross margin fell 430bp QoQ to 16.8%, operating margin printed just 1.4% (aided by $341M of interest income and $590M of other income), FCF was −$1.1B, and SBC (~$3.8B) now equals TTM net income with shares up 23% YoY — the multiple rests on unrealized optionality (Robotaxi/Optimus have no revenue line yet). The most recent hard evidence is bearish too: the Sep 25 rejection of the 380–387 shelf on the week's heaviest volume, a decelerating MACD histogram, a sold Semi launch, and a BNP Paribas target cut to $268. Why not sell outright: the bull's material is real — TTM revenue of $103.6B (+9.3%), a $27.4B net-cash fortress, a Q3 delivery report due within two weeks in Tesla's seasonally strongest quarter, and a breakout trigger only 4–6.5% overhead.
Action: reduce toward 0.3–0.5x standard allocation, executing the trim only into the 380–387 supply shelf via limit orders (~$384) — never as a market sale into mid-band chop — and deploy no fresh capital at $372. Holders who never get the bounce should hedge the retained position through the early-October Q3 delivery report with a put spread (long ~$350–355 / short ~$335–340) rather than a resting stop, given TSLA's documented gap risk. A weekly close above $395.62 (200-SMA) on volume is the flip trigger to rebuild toward neutral and then standard weight; a decisive daily close below $347–348 on heavy volume cuts the position to minimal, with $336–342 and then $298 as the next references. Reassess immediately after the Q3 delivery print.